Skip to main content
. 2023 Sep 8;114(11):4426–4432. doi: 10.1111/cas.15943

FIGURE 3.

FIGURE 3

Trends in attribution of HPV16 and HPV18 to invasive cervical cancer by age group: The MINT study, 2011–2022. Year‐on‐year trends of HPV16/18 prevalence (broken lines) and estimated prevalence trends (straight lines) among women diagnosed with invasive cervical cancer are shown for two age groups (2029 years [red] and 3039 years [green]). Asterisks indicate a marginally significant decline (p = 0.05).